BACKGROUND: Alterations in the cellular biological responses were examined in a series of LNCaP human prostate tumor cells growing under different conditions. MATERIALS AND METHODS: LNCaP cells were grown in two-dimensional monolayer cultures, three-dimensional spheroids, or as solid tumors in immune-deprived mice. RESULTS: As compared with the growth in the monolayers, cell growth in the spheroids was reduced, while VEGF production was increased. Immunohistochemical analysis of the spheroids revealed that cells showing Ki-67 up-regulation were localized in the peripheral layer, and that the central core was necrotic. The gene expression profile in the solid tumor tissue was obviously different from that in the monolayers; however, it was similar to that in the spheroids. The prostate-specific antigen levels in the culture supernatants of spheroids increased with time and decreased with anticancer agent treatment. CONCLUSION: Spheroid formation from human prostate tumor cells exhibits tissue-like features.
BACKGROUND: Alterations in the cellular biological responses were examined in a series of LNCaP humanprostate tumor cells growing under different conditions. MATERIALS AND METHODS: LNCaP cells were grown in two-dimensional monolayer cultures, three-dimensional spheroids, or as solid tumors in immune-deprived mice. RESULTS: As compared with the growth in the monolayers, cell growth in the spheroids was reduced, while VEGF production was increased. Immunohistochemical analysis of the spheroids revealed that cells showing Ki-67 up-regulation were localized in the peripheral layer, and that the central core was necrotic. The gene expression profile in the solid tumor tissue was obviously different from that in the monolayers; however, it was similar to that in the spheroids. The prostate-specific antigen levels in the culture supernatants of spheroids increased with time and decreased with anticancer agent treatment. CONCLUSION: Spheroid formation from humanprostate tumor cells exhibits tissue-like features.
Authors: Bhushan S Pattni; Srikar G Nagelli; Bhawani Aryasomayajula; Pranali P Deshpande; Abhijit Kulkarni; William C Hartner; Ganesh Thakur; Alexei Degterev; Vladimir P Torchilin Journal: Pharm Res Date: 2016-06-28 Impact factor: 4.200
Authors: Allen S W Oak; Georgeta Bocheva; Tae-Kang Kim; Anna A Brożyna; Zorica Janjetovic; Mohammad Athar; Robert C Tuckey; Andrzej T Slominski Journal: Anticancer Res Date: 2020-05 Impact factor: 2.480
Authors: Helmut Dolznig; Christian Rupp; Christina Puri; Christian Haslinger; Norbert Schweifer; Elisabeth Wieser; Dontscho Kerjaschki; Pilar Garin-Chesa Journal: Am J Pathol Date: 2011-04-30 Impact factor: 4.307
Authors: Matthias Saar; Hongjuan Zhao; Rosalie Nolley; Sarah R Young; Ilsa Coleman; Peter S Nelson; Robert L Vessella; Donna M Peehl Journal: Cancer Lett Date: 2014-07-03 Impact factor: 8.679
Authors: Brian J Engel; Pamela E Constantinou; Lindsey K Sablatura; Nathaniel J Doty; Daniel D Carson; Mary C Farach-Carson; Daniel A Harrington; Thomas I Zarembinski Journal: Adv Healthc Mater Date: 2015-06-09 Impact factor: 9.933